Project Details
Projekt Print View

Kidney Keratins, endogenous cytoprotective factors?

Subject Area Nephrology
Pathology
Term from 2016 to 2022
Project identifier Deutsche Forschungsgemeinschaft (DFG) - Project number 318056912
 

Final Report Abstract

Keratins (K) are a major component of the cell cytoskeleton of epithelial cells, providing for their mechanical integrity. Keratins also have protective functions in a variety of stress situations and diseases, best described for skin and the gastrointestinal tract. Tubular cells (TEC) are the most abundant kidney epithelial cells. During virtually all kidney diseases TEC are exposed to a number of stress stimuli. We showed that the major renal keratins are highly up-regulated in different animal models and patients with kidney diseases and could thereby serve as novel markers (i.e. diagnostic test) of TEC stress. We could substantiate these findings in different application scenarios. In ongoing work we also showed the regulation of previously unrecognized keratins in the kidneys, and showed the potential of a specific keratin, K18, and its fragments, as a potential diagnostic (serum or urinary) marker of kidney diseases in patients. Besides, the application helped us to provide scientific contribution and insights into chronic kidney diseases and renal fibrosis, specific kidney diseases and development of novel models, tissue diseases biomarker and non-invasive in vivo imaging, AI and deep learning augmented pathology diagnostics and a number of other studies. The project is in part followed in the recently established Clinical Research Unit 5011. Overall, our data suggest that keratins might be useful biomarkers of kidney tissue injury.

Publications

  • HIF stabilization inhibits renal epithelial cell migration and is associated with cytoskeletal alterations. Sci Rep 2018, 8:9497
    Müller S, Djudjaj S, Lange J, Iacovescu M, Goppelt-Struebe M, Boor P
    (See online at https://doi.org/10.1038/s41598-018-27918-9)
  • The protective role of macrophage migration inhibitory factor in acute kidney injury after cardiac surgery. Sci Transl Med 2018, 10:eaan4886
    Stoppe C, Averdunk L, Goetzenich A, Soppert J, Marlier A, Kraemer S, Vieten J, Coburn M, Stevanovic A, Kim B-S, Marx G, Rex S, Ochi A, Leng L, Moeckel G, Linkermann A, El Bounkari O, Zarbock A, Bernhagen J, Djudjaj S, Bucala R, Boor P
    (See online at https://doi.org/10.1126/scitranslmed.aan4886)
  • Elastin imaging enables non-invasive staging and treatment monitoring of kidney fibrosis. Sci Transl Med 2019, 11:eaat4865
    Sun Q, Baues M, Klinkhammer BM, Ehling J, Djudjaj S, Drude NI, Daniel C, Amann K, Kramann R, Kim H, Saez-Rodriguez J, Weiskirchen R, Onthank DC, Botnar RM, Kiessling F, Floege J, Lammers T, Boor P
    (See online at https://doi.org/10.1126/scitranslmed.aat4865)
  • Cellular and molecular mechanisms of kidney injury in 2,8-dihydroxyadenine nephropathy. J Am Soc Nephrol 2020, 31:799-816
    Klinkhammer BM, Djudjaj S, Kunter U, Palsson R, Edvardsson VO, Wiech T, Thorsteinsdottir M, Hardarson S, Foresto-Neto O, Mulay SR, Moeller MJ, Jahnen- Dechent W, Floege J, Anders HJ, Boor P
    (See online at https://doi.org/10.1681/asn.2019080827)
  • Collagen-specific molecular imaging of renal fibrosis. Kidney Int. 2020, 97:609-614
    Baues M, Klinkhammer BM, Ehling J, Gremse F, van Zandvoort MAMJ, Reutelingsperger CPM, Daniel C, Amann K, Bábíčková J, Kiessling F, Floege J, Lammers L, Boor P
    (See online at https://doi.org/10.1016/j.kint.2019.08.029)
  • Crystal clots as therapeutic target in cholesterol crystal embolism. Circulation Research 2020, 126:e37-e52
    Shi C, Kim T, Steiger S, Mulay SR, Klinkhammer BM, Bäuerle T, Melica ME, Romagnani P, Möckel D, Baues M, Yang L, Mammadova-Bach E, Sanne B, Heemskerk JWM, Braun A, Lammers T, Boor P, Anders HJ
    (See online at https://doi.org/10.1161/circresaha.119.315625)
  • Dysregulated mesenchymal PDGFR-β drives kidney fibrosis. EMBO Mol Med 2020, 12:e11021
    Buhl EM, Djudjaj S, Klinkhammer BM, Ermert K, Puelles VG, Lindenmeyer MT, Cohen CD, He C, Borkham-Kamphorst E, Weiskirchen R, Denecke B, Trairatphisan P, Saez- Rodriguez J, Huber TB, Olson LE, Floege J, Boor P
    (See online at https://doi.org/10.15252/emmm.201911021)
  • Decoding myofibroblast origin in human kidney fibrosis. Nature 2021, 589:281-286
    Kuppe C, Ibrahim M, Kranz J, Zhang X, Ziegler S, Jansen J, Reimer K, Peraales J, Smith R, Dobie R, Wilson-Kanamari J, Halder M, Xu Y, Kabgani N, Kaesler N, Klaus M, Gernhold L, Puelles V, Huber T, Boor P, Menzel S, Hoogenboezem R, Bindels E, Steffens J, Floege J, Schneider R, Saez-Rodriguez J, Henderson S, Kramann R
    (See online at https://doi.org/10.1038/s41586-020-2941-1)
  • Deep Learning-Based Segmentation and Quantification in Experimental Kidney Histopathology. J Am Soc Nephrol. 2021, 32:52-68
    Bouteldja N, Klinkhammer BM, Bülow RD, Droste P, Otten SW, Freifrau von Stillfried S, Moellmann J, Sheehan SM, Korstanje R, Menzel S, Bankhead P, Mietsch M, Drummer C, Lehrke M, Kramann R, Floege J, Boor P, Merhof D
    (See online at https://doi.org/10.1681/asn.2020050597)
 
 

Additional Information

Textvergrößerung und Kontrastanpassung